Active, Not Recruiting
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
NCT04401748
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Duplicate_Providence Medical Foundation /ID# 222633 Fullerton, California, United States
- University of California, Los Angeles /ID# 221760 Los Angeles, California, United States
- Torrance Memorial Physician Network Cancer Care /ID# 222702 Torrance, California, United States
- PIH Health Whittier Hospital /ID# 222647 Whittier, California, United States